[go: up one dir, main page]

ZA975959B - Method for the production of a therapeutic DNA. - Google Patents

Method for the production of a therapeutic DNA.

Info

Publication number
ZA975959B
ZA975959B ZA9705959A ZA975959A ZA975959B ZA 975959 B ZA975959 B ZA 975959B ZA 9705959 A ZA9705959 A ZA 9705959A ZA 975959 A ZA975959 A ZA 975959A ZA 975959 B ZA975959 B ZA 975959B
Authority
ZA
South Africa
Prior art keywords
production
therapeutic dna
dna
therapeutic
Prior art date
Application number
ZA9705959A
Other languages
English (en)
Inventor
Joel Crouzet
Beatrice Cameron
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA975959B publication Critical patent/ZA975959B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9705959A 1996-07-04 1997-07-03 Method for the production of a therapeutic DNA. ZA975959B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9608327A FR2750704B1 (fr) 1996-07-04 1996-07-04 Procede de production d'adn therapeutique

Publications (1)

Publication Number Publication Date
ZA975959B true ZA975959B (en) 1998-01-30

Family

ID=9493705

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9705959A ZA975959B (en) 1996-07-04 1997-07-03 Method for the production of a therapeutic DNA.

Country Status (14)

Country Link
US (2) US6410273B1 (xx)
EP (1) EP0914418A1 (xx)
JP (1) JP2000514293A (xx)
KR (1) KR20000022488A (xx)
AU (1) AU722909B2 (xx)
BR (1) BR9710173A (xx)
CA (1) CA2258792A1 (xx)
CZ (1) CZ438298A3 (xx)
FR (1) FR2750704B1 (xx)
IL (1) IL127620A0 (xx)
NO (1) NO986177L (xx)
SK (1) SK181498A3 (xx)
WO (1) WO1998001540A1 (xx)
ZA (1) ZA975959B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026468B2 (en) 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
US7026155B2 (en) * 1999-02-02 2006-04-11 Regents Of The University Of California Method of reducing bacterial proliferation
EP1319082B1 (en) * 2000-09-18 2005-11-16 Genzyme Corporation Expression vectors containing hybrid ubiquitin promoters
GB0025913D0 (en) * 2000-10-23 2000-12-06 Guldberg Per Materials and methods relating to nucleic acid amplification and profiling
US20030152950A1 (en) * 2001-06-27 2003-08-14 Garner Harold R. Identification of chemically modified polymers
US8119365B2 (en) * 2002-01-23 2012-02-21 Wisconsin Alumni Research Foundation Insertion sequence-free bacteria
US8765408B2 (en) 2002-01-23 2014-07-01 Wisconsin Alumni Research Foundation Prophage element-free bacteria
US6989265B2 (en) * 2002-01-23 2006-01-24 Wisconsin Alumni Research Foundation Bacteria with reduced genome
US8039243B2 (en) * 2002-01-23 2011-10-18 Wisconsin Alumni Research Foundation Insertion sequence-free bacteria
US20060270043A1 (en) * 2002-01-23 2006-11-30 Blattner Frederick R Bacteria with reduced genome
US7303906B2 (en) 2002-09-06 2007-12-04 Wisconsin Alumni Research Foundation Competent bacteria
US20090191218A1 (en) 2005-05-11 2009-07-30 Fengchun Li DNA Vaccines And Methods For The Prevention Of Transplantation Rejection
CA2607214C (en) * 2005-05-11 2010-11-02 Loma Linda University Substances, compositions and methods for preventing and treating immune-mediated inflammatory disorders
EP3351252B1 (en) * 2006-09-28 2020-04-22 Loma Linda University Apoptotic cell-mediated transfection of mammalian cells with interfering rna
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
DK2758074T3 (da) 2011-09-23 2020-07-27 Univ Loma Linda Bakteriestammer der udtrykker methylasegener og anvendelser deraf
US11680273B2 (en) 2011-09-23 2023-06-20 Loma Linda University Treatment of autoimmune diseases
US12180487B2 (en) * 2019-02-06 2024-12-31 Fred Hutchinson Cancer Center Minicircle producing bacteria engineered to differentially methylate nucleic acid molecules therein

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5491060A (en) * 1989-05-01 1996-02-13 The University Of Maryland Mutant strain of E. coli for detection of methyltransferase clones
EP0412676B1 (en) * 1989-08-07 1995-06-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for producing the spiroplasma SP. DNA methylase
US5405760A (en) * 1992-04-30 1995-04-11 New England Biolabs, Inc. Process for producing recombinant McrBC endonuclease and cleavage of methylated DNA
US5470740A (en) * 1993-11-04 1995-11-28 Life Technologies, Inc. Cloned NsiI restriction-modification system
US5587305A (en) * 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
FR2714830B1 (fr) 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
EP0772619B2 (en) * 1994-07-15 2010-12-08 The University of Iowa Research Foundation Immunomodulatory oligonucleotides
FR2730637B1 (fr) 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
FR2739292B1 (fr) 1995-09-28 1997-10-31 Rhone Poulenc Rorer Sa Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations
FR2741066B1 (fr) 1995-11-14 1997-12-12 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
FR2754272B1 (fr) 1996-10-08 1998-11-13 Rhone Poulenc Rorer Sa Procede de preparation de compositions pour le transfert d'acides nucleiques
US6060245A (en) 1996-12-13 2000-05-09 Stratagene Methods and adaptors for generating specific nucleic acid populations

Also Published As

Publication number Publication date
JP2000514293A (ja) 2000-10-31
FR2750704B1 (fr) 1998-09-25
EP0914418A1 (fr) 1999-05-12
IL127620A0 (en) 1999-10-28
CZ438298A3 (cs) 1999-04-14
US6410273B1 (en) 2002-06-25
NO986177L (no) 1999-02-15
SK181498A3 (en) 1999-07-12
NO986177D0 (no) 1998-12-29
US20020187527A1 (en) 2002-12-12
AU3447597A (en) 1998-02-02
WO1998001540A1 (fr) 1998-01-15
AU722909B2 (en) 2000-08-17
BR9710173A (pt) 1999-08-10
FR2750704A1 (fr) 1998-01-09
KR20000022488A (ko) 2000-04-25
CA2258792A1 (fr) 1998-01-15

Similar Documents

Publication Publication Date Title
ZA975959B (en) Method for the production of a therapeutic DNA.
ZA9811382B (en) Process for the production of N-propanol.
ZA995444B (en) A method for the treatment of staphylococcal disease.
ZA989631B (en) Process for the production of N-Butanol.
IL133363A (en) Process for the production of herapin
ZA9710114B (en) Method for the expression of genes.
IL119612A0 (en) Method for the production of khalas
ZA966603B (en) Therapeutic method.
HUP9901029A3 (en) Method for the production of rdspa alfa1
EP0990658A4 (en) PROCESS FOR PRODUCING TRIHYDROCARBYLALUMINUMS
ZA9710349B (en) Process for making benzisothiazolin-3-ones.
SG72861A1 (en) Process for producing 7-octen-1-al
HU9802054D0 (en) Process for producing pentafluorpentanol
SG78300A1 (en) Production process
GB9510194D0 (en) Production method
HUP9802955A3 (en) Process for producing amino-cyano-acetamide
HU9701137D0 (en) Process for producing pharmaceutical intermedier
GB9602805D0 (en) Production process
HUP9904497A3 (en) Method for the production of ivermectin
IL136026A0 (en) Process for the production of formylimidazoles
HU9801800D0 (en) Process for producing 1-pyruvyl-l-proline
EP0670311A3 (de) Verfahren zur Herstellung von Piperid-2-on.
GB9604564D0 (en) Production method
HUP9902747A3 (en) Method for producing therapeutic dna
HUP9902584A3 (en) Process for the production of 2h-1-benzopyrans